Format

Send to

Choose Destination
Skin Pharmacol. 1996;9(2):93-8.

Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids.

Author information

1
Department of Dermatology, Humboldt University, Berlin, Germany.

Abstract

Mast cells are well known effector cells not only in allergic but also in diverse acute and chronic inflammatory diseases. We have shown previously that these cells produce a broad spectrum of cytokines which might contribute to mast cell-dependent pathology. In the present study, we have investigated the influence of four potent glucocorticoids, methylprednisolone-aceponate, methylprednisolone-17-propionate, prednicarbate, and betametasone valerate (10(-5) M-10(-9) M), on the IL-1 beta, IL-3, IL-8, and tumor necrosis factor alpha secretion of the HMC-1 mast cell line as measured by ELISA. All four glucocorticoids caused a comparable dose- and time-dependent inhibition of cytokine release from HMC-1 cells stimulated for 24 h with phorbol 12-myristate 13-acetate 25 ng/ml and calcium ionophore 2 x 10(-7) M. These results shed further light on the mechanisms involved in antiinflammatory effects of glucocorticoids in allergic inflammation.

PMID:
8722602
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center